aTyr Pharma, Inc., a bio-therapeutics company, has announce its first quarter results for FY-2015-16.
The results shows Net Loss widens from -$6.093 Million to -$9.071 Million YoY, while cash and cash reserves increased from %15.853 Million to $54.512 Million quarterly.
Yearly Quarter Comparison
Research & Development expenses Rise from $4.4 Million to $6.6 Million.
General and Admin Expenses also rise from $1.5 Million to $2.3 Million.
Prior to the private placement the Assets rose from $20.644 Million to $59.905 Million.
View the full earnings release here.